Capital Research Global Investors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$442M Buy
2014
Q4
$378M Buy
2014
Q3
$279M Buy
2014
Q2
$424M Buy
2014
Q1
$335M Buy
2013
Q4
$244M Buy
2013
Q3
$223M Buy
2013
Q2
$140M Buy